Imaging of multidrug resistance in cancer - Wikidata - awgldk - TriplyDB

Imaging of multidrug resistance in cancer

Imaging of multidrug resistance in cancer

http://www.wikidata.org/entity/Q34823564

about

In vivo imaging of multidrug resistance using a third generation MDR1 inhibitor.Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells.Mathematical Simulation of Transport Kinetics of Tumor-Imaging Radiopharmaceutical 99mTc-MIBI Effects of Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitro Astragalus polysaccharides can regulate cytokine and P-glycoprotein expression in H22 tumor-bearing mice.Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.Molecular Imaging of P-glycoprotein in Chemoresistant Tumors Using a Dual-Modality PET/Fluorescence Probe.Nuclear oncology in Cancer Imaging 2011.PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways.99mTc-Sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide.

P2860

Q30583710-F9FFF34F-6F95-401D-BA26-6181D4AF8C31 Q33798970-73DC2C38-C721-441B-8221-806CB9E4BF52 Q33862496-6A865ECA-9B53-4B52-A28C-9C7B81F6E7F9 Q34333351-28C46E7A-11CD-4D35-B37D-2E99114DB923 Q36492677-6FED8768-19BB-4A41-AD50-557B0589A9BF Q38213800-63C3FB9A-A719-4E7C-800B-788317B4FBDA Q42798231-4E91B5B8-2431-48FB-B368-616A15252CD5 Q43218520-F44928E1-E936-4B98-8D82-33E1226E12F8 Q47289144-D3014EB3-2F3F-4B25-B076-2A939BB6A24D Q50133865-E19FCC05-64C8-40D5-B852-C758907BC9BB

P2860

Imaging of multidrug resistance in cancer

http://www.wikidata.org/entity/Q34823564

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Imaging of multidrug resistance in cancer

@ast

Imaging of multidrug resistance in cancer

@en

Imaging of multidrug resistance in cancer

@nl

type

label

Imaging of multidrug resistance in cancer

@ast

Imaging of multidrug resistance in cancer

@en

Imaging of multidrug resistance in cancer

@nl

prefLabel

Imaging of multidrug resistance in cancer

@ast

Imaging of multidrug resistance in cancer

@en

Imaging of multidrug resistance in cancer

@nl

P1433

Q34823564-15CAEBC8-49F6-47EF-9778-9586F280B1BA

P1476

Q34823564-136D12F1-2A93-4B5F-8A27-F72DB4071D5A

P2093

Q34823564-34ABAEE4-7D2C-4964-AE48-4B25A46F9740

Q34823564-404FC095-1632-431C-A32E-225EF9DDACE5

P2860

Q34823564-02B0513C-AB13-4822-9F63-F533301D47C3

Q34823564-04F3BC15-E305-48FE-89EF-A85901EFC725

Q34823564-16AD292A-286C-4E01-B0E1-C6F73F28F678

Q34823564-2250BF8B-DDDA-4774-A53A-4FB01CE2143E

Q34823564-2425AB0B-F14D-425E-9A9F-61AA2C3A7ADB

Q34823564-25A2087A-BA39-464C-8489-186A31EDCC57

Q34823564-2B9F37EB-7710-467B-8764-3375B7008CD1

Q34823564-2E1848F7-E49C-41B0-B05D-36240DD4B905

Q34823564-2EB34084-D6A5-4CE7-9424-EF3EB6BFE5FB

Q34823564-2F7D23B7-4293-40BB-A86F-9AEFEC3E133D

P304

Q34823564-FADFA6B1-39D5-4AEE-B02B-9B493F7EBECC

P31

Q34823564-828A696F-65B4-4417-B6BF-5852A824BA15

Q34823564-D0969B77-9145-4787-8E74-9E9942BE5519

P356

Q34823564-48971E86-1BE3-404A-9270-278892C41046

P478

Q34823564-E53838B9-D633-4405-B473-404D0AA1B859

P577

Q34823564-A25710BA-38F4-4491-9D88-9ACC5938D5C5

P5875

Q34823564-C444A2A8-DD15-4FA6-9B84-E59DFC7847E2

P698

Q34823564-6D53EE23-ABDA-4781-839A-56CC33B49C74

P921

Q34823564-0D6A2490-CE48-4274-9382-2EEBDF6B3D69

Q34823564-37BEC07A-0A89-4A12-B17D-4FC4656B382E

Q34823564-A7AE8756-7169-443A-BBA4-64A595E487CE

Q34823564-D315FF43-A099-4DD5-A83A-EAE30A5787DE

Q34823564-DDE11EAE-B501-4EBE-99B8-7EC655C81262

P932

Q34823564-EA2C5A79-BC08-4EFD-90C6-690D4AFAA34E

P356

1470-7330.2011.0001

P1433

P1476

Imaging of multidrug resistance in cancer

@en

P2093

A M Peters

http://www.w3.org/2001/XMLSchema#string

S Dizdarevic

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding

99mTc-tetrofosmin for functional imaging of P-glycoprotein modulation in vivo.

ABC multidrug transporters: structure, function and role in chemoresistance.

Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet?

A review of the cost-effectiveness of Tc-99m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast.

Genetically determined differences in P-glycoprotein function: implications for disease risk.

Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.

Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1102/1470-7330.2011.0001

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50249584

http://www.w3.org/2001/XMLSchema#string

P698

21362586

http://www.w3.org/2001/XMLSchema#string

P921

transport protein

membrane proteins

multiple drug resistance

physiological phenomena

P932

3080121

http://www.w3.org/2001/XMLSchema#string